Compare Unichem Lab with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB NOVARTIS UNICHEM LAB/
NOVARTIS
 
P/E (TTM) x -47.2 2,073.7 - View Chart
P/BV x 1.2 27.5 4.2% View Chart
Dividend Yield % 1.2 1.6 74.4%  

Financials

 UNICHEM LAB   NOVARTIS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
NOVARTIS
Mar-19
UNICHEM LAB/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs292980 29.8%   
Low Rs182600 30.3%   
Sales per share (Unadj.) Rs167.7198.7 84.4%  
Earnings per share (Unadj.) Rs-3.621.0 -17.3%  
Cash flow per share (Unadj.) Rs5.922.3 26.7%  
Dividends per share (Unadj.) Rs4.0010.00 40.0%  
Dividend yield (eoy) %1.71.3 133.4%  
Book value per share (Unadj.) Rs372.3307.5 121.1%  
Shares outstanding (eoy) m70.3824.69 285.1%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.44.0 35.6%   
Avg P/E ratio x-65.337.7 -173.2%  
P/CF ratio (eoy) x39.935.5 112.4%  
Price / Book Value ratio x0.62.6 24.8%  
Dividend payout %-110.247.7 -231.0%   
Avg Mkt Cap Rs m16,68019,508 85.5%   
No. of employees `0002.60.6 447.8%   
Total wages/salary Rs m2,3931,171 204.4%   
Avg. sales/employee Rs Th4,535.28,445.4 53.7%   
Avg. wages/employee Rs Th919.82,015.7 45.6%   
Avg. net profit/employee Rs Th-98.2891.0 -11.0%   
INCOME DATA
Net Sales Rs m11,8014,907 240.5%  
Other income Rs m984783 125.7%   
Total revenues Rs m12,7855,689 224.7%   
Gross profit Rs m-835123 -679.9%  
Depreciation Rs m67432 2,118.6%   
Interest Rs m7516 473.0%   
Profit before tax Rs m-600858 -69.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-343340 -101.0%   
Profit after tax Rs m-256518 -49.4%  
Gross profit margin %-7.12.5 -282.7%  
Effective tax rate %57.339.6 144.5%   
Net profit margin %-2.210.6 -20.5%  
BALANCE SHEET DATA
Current assets Rs m20,3848,055 253.1%   
Current liabilities Rs m5,0291,850 271.8%   
Net working cap to sales %130.1126.4 102.9%  
Current ratio x4.14.4 93.1%  
Inventory Days Days10545 232.7%  
Debtors Days Days13534 397.7%  
Net fixed assets Rs m9,023150 6,023.6%   
Share capital Rs m141123 114.1%   
"Free" reserves Rs m26,0587,469 348.9%   
Net worth Rs m26,1997,592 345.1%   
Long term debt Rs m00-   
Total assets Rs m31,4969,824 320.6%  
Interest coverage x-7.054.9 -12.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.5 75.0%   
Return on assets %-0.65.4 -10.5%  
Return on equity %-1.06.8 -14.3%  
Return on capital %-2.011.5 -17.4%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18858 14,215.3%   
Fx outflow Rs m5961,326 44.9%   
Net fx Rs m7,592-1,269 -598.4%   
CASH FLOW
From Operations Rs m-3,278-1,943 168.7%  
From Investments Rs m-2,8602,742 -104.3%  
From Financial Activity Rs m-24-298 8.1%  
Net Cashflow Rs m-4,690501 -935.6%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 15.1 2.0 755.0%  
FIIs % 3.0 1.6 187.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 21.5 147.4%  
Shareholders   20,176 41,647 48.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   IPCA LABS  GSK PHARMA  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  SANOFI INDIA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Nosedived 1,939 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended deep in the red.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 26, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ALEMBIC PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS